PROSTATE CANCER RESEARCH — grant history
Latest income
£5.2m
Grants listed (FY2025)
32
Listed grants total
£2.6m
Accounts grants total
£1.1m
listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts
Application guidance — from the funder’s own website
- How to apply: The website lists a link to 'Apply to our Seed Grants' under the 'PCR Funding for Scientists' section, but does not provide specific instructions, forms, or eligibility criteria on this page.
What this funder supports
Causes funded
Where grantees operate
- Throughout England And Wales
- Cardiff
- Northern Ireland
- Scotland
What changed: FY2024 → FY2025
| Change | Grantee | FY2024 | FY2025 |
|---|---|---|---|
| up | CRUK Beatson Institute | £59k | £96k |
| not listed | Other Grants costs | £46k | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| University of Cambridge | FY2025 | £248k | Liquid Biopsy |
| University of Cambridge | FY2025 | £199k | PTEN and TSGs |
| Cardiff University | FY2025 | £162k | Bone mets/Wnt |
| University of East Anglia | FY2025 | £128k | Al/Mathematical Classification |
| University of East Anglia | FY2025 | £122k | Disparities/PCR test |
| Imperial College London | FY2025 | £121k | Obesity-driven PC |
| Newcastle University | FY2025 | £121k | Bone mets/glycans |
| University of Cambridge | FY2025 | £114k | ProCASP |
| Imperial College London | FY2025 | £113k | Obesity-driven PC |
| University of Oxford | FY2025 | £105k | 177Lu-PSMA |
| University of Oxford | FY2025 | £105k | 177Lu-PSMA |
| University of Sunderland | FY2025 | £105k | Disparities/Barriers to early diagnosis |
| University of Aberdeen | FY2025 | £98k | SoloMERS |
| CRUK Beatson Institute | FY2025 | £96k | MCL-1 |
| Newcastle University | FY2025 | £93k | Bone mets/glycans |
| Cardiff University | FY2025 | £86k | Bone mets/Wnt |
| Newcastle University | FY2025 | £82k | AR-V Splicing |
| University of Cambridge | FY2025 | £82k | ProCASP |
| CRUK Beatson Institute | FY2025 | £59k | MCL-1 |
| Newcastle University | FY2025 | £50k | Bone mets/glycans |
| University of Essex | FY2025 | £47k | Disparities/AR risk |
| Newcastle University | FY2025 | £46k | AR-V Splicing |
| Kings College London | FY2025 | £41k | PlexinB1 |
| University of East Anglia | FY2025 | £41k | Disparities/PCR test |
| UCL | FY2025 | £38k | STAMPEDE |
| Imperial College London | FY2025 | £36k | MmicroRNA-346 |
| UCL | FY2025 | £35k | Disparities/treatment patterns |
| University of Sunderland | FY2025 | £21k | Disparities/Barriers to early diagnosis |
| UCL | FY2025 | £19k | Disparities/treatment patterns |
| University of East Anglia | FY2025 | £15k | Al/Mathematical Classification |
| UCL | FY2025 | £13k | STAMPEDE |
| Imperial College London | FY2025 | £1k | EPI-EVO |
| University of Cambridge | FY2024 | £199k | PTEN and TSGs |
| Cardiff University | FY2024 | £162k | Bone mets/Wnt |
| University of East Anglia | FY2024 | £128k | AI/Mathematical Classification |
| University of East Anglia | FY2024 | £122k | Disparities/PCR test |
| Imperial College London | FY2024 | £121k | Obesity-driven PC |
| University of Oxford | FY2024 | £105k | 177Lu-PSMA |
| University of Sunderland | FY2024 | £105k | Disparities/Barriers to early diagnosis |
| University of Aberdeen | FY2024 | £98k | SoloMERS |
| Newcastle University | FY2024 | £93k | Bone mets/glycans |
| Newcastle University | FY2024 | £82k | AR-V Splicing |
| University of Cambridge | FY2024 | £82k | ProCASP |
| CRUK Beatson Institute | FY2024 | £59k | MCL-1 |
| Newcastle University | FY2024 | £50k | Bone mets/glycans |
| University of Essex | FY2024 | £47k | Disparities/AR risk |
| Other Grants costs | FY2024 | £46k | |
| Kings College London | FY2024 | £41k | PlexinB1 |
| UCL | FY2024 | £38k | STAMPEDE |
| UCL | FY2024 | £35k | Disparities/treatment patterns |
| Cambridge University | FY2023 | £148k | Wnt Signalling |
| Aberdeen University | FY2023 | £144k | Bone mets/Targeting Signalling |
| King's College London | FY2023 | £137k | Immunotherapy |
| University of East Anglia | FY2023 | £134k | Machine learning models |
| Cardiff University | FY2023 | £134k | PlexinB1 |
| University of Sunderland | FY2023 | £122k | Al/Mathematical Classification |
| Oxford University | FY2023 | £98k | ProCASP |
| Cancer Research UK | FY2023 | £86k | AR-V Splicing |
| Other Grants costs | FY2023 | £70k | Targeting MCL-1 |
| UCL | FY2023 | £52k | 177Lu-PSMA |
| Newcastle University | FY2023 | £51k | Solo MERS |
| Imperial College London | FY2023 | £49k | Glycan drugs targeting bone metastasis |
| Francis Crick institute | FY2023 | £48k | PTEN and TSGs |
| Other Grants costs | FY2023 | £34k | Disparities/AR risk |
| University of Essex | FY2023 | £31k | STAMPEDE |
| Other Grants costs | FY2023 | £22k | Disparities/Barriers to early diagnosis |
| Other Grants costs | FY2023 | £12k | Obesity and Prostate Cancer |
| King’s College London | FY2022 | £137k | Immunotherapy |
| Cardiff University | FY2022 | £134k | PlexinB1 |
| Newcastle University | FY2022 | £122k | ProCASP |
| UCL | FY2022 | £113k | Machine learning models |
| Cancer Research UK | FY2022 | £112k | 177Lu-PSMA |
| Francis Crick institute | FY2022 | £86k | Targeting Wnt Signalling |
| Cambridge University | FY2022 | £80k | Wnt Signalling |
| Other Grants costs | FY2022 | £70k | Glycan drugs targeting bone metastasis |
| Aberdeen University | FY2022 | £52k | Modelling |
| Other Grants costs | FY2022 | £51k | Obesity and Prostate Cancer |
| Oxford University | FY2022 | £49k | PTEN and TSGs |
| Imperial College London | FY2022 | £44k | AR-V Splicing |
| University of East Anglia | FY2022 | £40k | SoloMERS |
| Other Grants costs | FY2022 | £34k | Targeting MCL-1 |
| Other Grants costs | FY2022 | £22k | STAMPEDE |
| Other Grants costs | FY2022 | £12k | AI/Mathematical Classification |